Finance

Lists
Why is GYRE up 4,15%?
Dive Deeper
GYRE:NASDAQ
Gyre Therapeutics Inc
4,52 USD
+4,15%
(+0,18) 1D
4,56 USD
+0,88% (+0,040)
After hours
Closed: 19-ноя., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
4,47 USD
High
4,70 USD
Low
4,34 USD
Mkt. cap
494,72 млн
Avg. vol.
203,34 миң
Volume
268,93 миң
52-wk high
9,14 USD
52-wk low
4,00 USD
EPS
-0,27 USD
Beta
2,43
Shares outstanding
106,03 млн
No. of employees
625
Open
4,47 USD
High
4,70 USD
Low
4,34 USD
Mkt. cap
494,72 млн
Avg. vol.
203,34 миң
Volume
268,93 миң
52-wk high
9,14 USD
52-wk low
4,00 USD
EPS
-0,27 USD
Beta
2,43
Shares outstanding
106,03 млн
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
HeadquartersУинстон-Сейлем, Север Каролина, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitegyretx.com
Analyst ratings
Based on 1 analyst giving stock ratings to GYRE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GYRE in the last 3 months
Highest
Current 4,52 USD
18,00 USD (+298,23%)
Average
18,00 USD (+298,23%)
Lowest
18,00 USD (+298,23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
18,00 USD
+298,2%
11/06/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
20,00 USD
+342,5%
08/10/2026
Roger Song
Jefferies
Buy
Initiated
16,00 USD
+254%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
37,20 млн
24,43 млн
29,10 млн
32,93 млн
Cost of goods sold
1,74 млн
1,23 млн
2,21 млн
1,95 млн
Cost of revenue
1,74 млн
1,23 млн
2,21 млн
1,95 млн
Research and development expenses
4,82 млн
11,48 млн
19,14 млн
8,51 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30,52 млн
24,31 млн
21,62 млн
23,95 млн
Operating expense
35,33 млн
35,79 млн
40,76 млн
32,46 млн
Total operating expenses
37,08 млн
37,02 млн
42,97 млн
34,40 млн
Operating income
120,00 миң
-12,59 млн
-13,86 млн
-1,47 млн
Other non operating income
-2,31 млн
244,00 миң
-1,19 млн
-913,00 миң
EBT including unusual items
-66,00 миң
-18,03 млн
-18,34 млн
-1,74 млн
EBT excluding unusual items
-864,00 миң
-11,65 млн
-13,93 млн
-1,70 млн
Income tax expense
1,30 млн
549,00 миң
-164,00 миң
733,00 миң
Effective tax rate
-1 969,70%
-3,04%
0,89%
-42,01%
Other operating expenses
-
-
-
-
Net income
-1,72 млн
-10,30 млн
-14,51 млн
-4,05 млн
Net profit margin
-4,63%
-42,16%
-49,85%
-12,31%
Earnings per share
0,05
-
-
-
Interest and investment income
1,35 млн
743,00 миң
1,14 млн
688,00 миң
Interest expense
-
-
-
-
Net interest expenses
1,35 млн
743,00 миң
1,14 млн
688,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
815,00 миң
-11,92 млн
-12,38 млн
-1,00 млн
Gain or loss from assets sale
2,00 миң
16,00 миң
2,00 миң
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору